Secondary Logo

Share this article on:

Diabetic autonomic neuropathy resulting in sexual dysfunction

doi: 10.1097/01.NPR.0000547542.28090.64
CE Connection

For more than 274 additional continuing-education articles related to Advanced Practice Nursing topics, go to NursingCenter.com/CE.

Earn CE credit online: Go to www.nursingcenter.com/CE/NP and receive a certificate within minutes.

Starting with the January 2019 issue, The Nurse Practitioner will no longer facilitate mail-in continuing-education tests, and all CE tests must be taken online at www.nursingcenter.com/ce/np. Please address any questions to customer service at 1-800-787-8985.

Back to Top | Article Outline

INSTRUCTIONS Diabetic autonomic neuropathy resulting in sexual dysfunction

TEST INSTRUCTIONS

  • To take the test online, go to our secure website at www.nursingcenter.com/ce/NP. View instructions for taking the test online there.
  • If you prefer to submit your test by mail, record your answers in the test answer section of the CE enrollment form on page 46. You may make copies of the form.
  • Each question has only one correct answer. There is no minimum passing score required.
  • Complete the registration information and course evaluation. Mail the completed form and registration fee of $12.95 to: Lippincott Professional Development CE Group, 74 Brick Blvd., Bldg. 4, Suite 206, Brick, NJ 08723. We will mail your certificate in 4 to 6 weeks. For faster service, include a fax number and we will fax your certificate within 2 business days of receiving your enrollment form. You will receive your CE certificate of earned contact hours and an answer key to review your results.
  • Registration deadline is September 4, 2020.
Back to Top | Article Outline

DISCOUNTS and CUSTOMER SERVICE

  • Send two or more tests in any nursing journal published by Lippincott Williams & Wilkins together and deduct $0.95 from the price of each test.
  • We also offer CE accounts for hospitals and other healthcare facilities on nursingcenter.com. Call 1-800-787-8985 for details.
Back to Top | Article Outline

PROVIDER ACCREDITATION

Lippincott Professional Development will award 1.0 contact hour for this continuing nursing education activity.

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 1.0 contact hour. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia, Georgia, and Florida CE Broker #50-1223.

Diabetic autonomic neuropathy resulting in sexual dysfunction

General Purpose: To discuss the problem of DAN and its relationship with SD. Learning Objectives/Outcomes: After completing this continuing-education activity, you should be able to: 1. Review the etiology, risk factors, and pathophysiology of SD associated with DAN. 2. Describe the assessment and manifestations of SD associated with DAN. 3. Outline the recommended strategies for managing SD associated with DAN.

  1. SD as a manifestation of DAN begins when nerve cells are oversaturated with
    1. adenosine triphosphate.
    2. acetylcholine.
    3. glucose.
  2. Compared with men who do not have diabetes mellitus, men who have diabetes are how many times more likely to experience ED?
    1. two
    2. three
    3. four
  3. For women who have diabetes mellitus, hyperglycemia may result in SD because of
    1. dehydration.
    2. polyphagia.
    3. tachypnea.
  4. The risk of SD increases for women who have T2DM who take
    1. metformin.
    2. glipizide.
    3. insulin.
  5. A significant risk factor for ED is
    1. arthritis.
    2. advancing age.
    3. sedentary lifestyle.
  6. Approximately, what percentage overall of men who have either T1DM or T2DM experience problems maintaining or sustaining an erection?
    1. 25.5%
    2. 40%
    3. 52.5%
  7. The first symptom of ED is usually the inability to
    1. initiate an erection.
    2. sustain an erection.
    3. experience orgasm.
  8. Which of the following neurotransmitters transmits signals to the sex organs to begin the blood flow required for arousal?
    1. serotonin
    2. glutamate
    3. norepinephrine
  9. Bajaj and colleagues linked which of the following to a reduction in the quality of sexual performance?
    1. anemia
    2. depression
    3. hypogonadism
  10. Which of the following tests is a simple, noninvasive test used to determine the response of nerve cells to vibration, sensation, and temperature?
    1. evoked potentials
    2. electroneurography
    3. quantitative sensory test
  11. Which of the following reflects a disturbance in the autonomic nervous system?
    1. pulsus paradoxus
    2. orthostatic hypotension
    3. increased heart rate variability
  12. What test may be done in men with DAN to assess blood flow to the penis?
    1. penile duplex ultrasound
    2. nocturnal erection test
    3. bedtime ring-like device test
  13. Which of the following is among the most common SD manifestations in men who have diabetes?
    1. priapism
    2. depression
    3. premature ejaculation
  14. Which of the following is not a common adverse reaction of PDE-5 inhibitors?
    1. headache
    2. dyspepsia
    3. hearing loss
  15. A serious interaction can occur if patients take a PDE-5 inhibitor while also taking
    1. a beta-blocker.
    2. an organic nitrate.
    3. a nonsteroidal anti-inflammatory drug.
  16. Antidepressants that have low to no impact on sexual function include
    1. amitriptyline.
    2. bupropion.
    3. sertraline.
  17. The A1C level should remain below 7% for
    1. men with SD who do not have diabetes.
    2. postmenopausal women with SD who do not have diabetes.
    3. most nonpregnant adults with diabetes.
  18. According to Dhikav and colleagues, which modality was significantly effective in improving six domains of SD in women 45 and older?
    1. yoga
    2. tai chi
    3. Pilates
Figure

Figure

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.